Literature DB >> 18633970

Production of micronic particles of biocompatible polymer using supercritical carbon dioxide.

L Benedetti1, A Bertucco, P Pallado.   

Abstract

Three micronization techniques, based on the use of supercritical carbon dioxide, were investigated to produce microspheres of a natural biocompatible polysaccharide. Particles smaller than 20 mum were obtained by means of the rapid expansion of a supercritical solution method (RESS), both with and without cosolvents. The mean diameter of the particles was reduced to about 0.5 mum when a solution of the polymer in an organic solvent was expanded by using carbon dioxide as a supercritical antisolvent (SAS). The SAS process was operated both in a continuous and in a batch mode. The former leads to aggregated structures and fibers, and the latter to the formation of micronic spherical particles. It was found that the experimental temperature did not substantially affect the shape and dimension of the particles. A stronger dependence is shown with respect to the solute concentration in the starting solution. The proposed method is attractive as the basis of a new process for the preparation of drug delivery systems. (c) 1997 John Wiley & Sons, Inc.

Entities:  

Year:  1997        PMID: 18633970     DOI: 10.1002/(SICI)1097-0290(19970120)53:2<232::AID-BIT15>3.0.CO;2-M

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  3 in total

Review 1.  Phase behavioral effects on particle formation processes using supercritical fluids.

Authors:  S Palakodaty; P York
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide.

Authors:  R T Bustami; H K Chan; F Dehghani; N R Foster
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

3.  Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.

Authors:  Todd M Martin; Nagesh Bandi; Ryan Shulz; Christopher B Roberts; Uday B Kompella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.